PRTT (Protect Pharmaceutical) YoY EBITDA Growth: 98.89% (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Protect Pharmaceutical YoY EBITDA Growth?

Protect Pharmaceutical PRTT YoY EBITDA Growth is 98.89% as of Jun. 2018.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Protect Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Jun. 2018 was 98.89%.

Protect Pharmaceutical's EBITDA per Share for the three months ended in Jun. 2018 was $-0.00.

Protect Pharmaceutical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Protect Pharmaceutical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical YoY EBITDA Growth Chart

Protect Pharmaceutical Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 95.67 -7.69 88.15 44.12 -150.00

Protect Pharmaceutical Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -900.00 100.00 100.00 100.00 98.89

Protect Pharmaceutical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Protect Pharmaceutical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2017 is calculated as:

YoY EBITDA Growth (A: Dec. 2017 )
=(EBITDA per Share (A: Dec. 2017 )-EBITDA per Share (A: Dec. 2016 ))/ | EBITDA per Share (A: Dec. 2016 ) |
=(-0.095--0.038)/ | -0.038 |
=-150.00 %

Protect Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Jun. 2018 is calculated as:

YoY EBITDA Growth (Q: Jun. 2018 )
=(EBITDA per Share (Q: Jun. 2018 )-EBITDA per Share (Q: Jun. 2017 )) / | EBITDA per Share (Q: Jun. 2017 )) |
=(-0.001--0.09)/ | -0.09 |
=98.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 98.89% mean?
Protect Pharmaceutical (PRTT) has a YoY EBITDA Growth of 98.89% as of Jun. 2018. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Protect Pharmaceutical and its competitors.
Is Protect Pharmaceutical's YoY EBITDA Growth too high?
Protect Pharmaceutical's current YoY EBITDA Growth is 98.89%.
How does Protect Pharmaceutical's YoY EBITDA Growth compare to PVEG and FCIC?
Protect Pharmaceutical's YoY EBITDA Growth of 98.89% can be compared against companies in the Transportation industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Transportation company?
A good YoY EBITDA Growth depends on the Transportation industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Protect Pharmaceutical and its competitors. Protect Pharmaceutical's current YoY EBITDA Growth is 98.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Protect Pharmaceutical stock overvalued right now?
Protect Pharmaceutical (PRTT) has a current YoY EBITDA Growth of 98.89%. The current YoY EBITDA Growth is 98.89%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Protect Pharmaceutical (PRTT), the current YoY EBITDA Growth is 98.89% as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Protect Pharmaceutical Business Description

Address 30 N Gould St, Suite R, Sheridan, WY, USA, 82801
Protect Pharmaceutical Corp is engaged in Textiles and Software as a Service.